Maryland Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Healthcare Reporter.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 31, 2026

Mar. 31, 2026

Spartan Medical and Headsafe US Inc. Announce U.S. Partnership to Expand Access to Objective Concussion Assessment

EIN Presswire

Mar. 31, 2026

The Myositis Association Selected for NIH NOURISH Autoimmunity Challenge

EIN Presswire

Mar. 31, 2026

NEW color2check from BYK-Gardner

EIN Presswire

Mar. 31, 2026

RadSite CEO Marks 30 Years in the Accreditation Field

EIN Presswire

Mar. 31, 2026

Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly

GlobeNewswire

Mar. 31, 2026

Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation

GlobeNewswire

Mar. 31, 2026

Your Next Dental Appointment May Save Your Life

GlobeNewswire

Mar. 31, 2026

Frederick Residents Bring GreenLight Mobility To Maryland

EIN Presswire

Mar. 31, 2026

Intermountain Health Primary Children’s Hospital Among First in the West to Join National Trauma & Grief Network

GlobeNewswire

Mar. 31, 2026

Global Ion Exchange Materials Market to Reach $5.9 Billion by 2030, Driven by Green Hydrogen, Water Treatment Standards and Energy Security Demands

GlobeNewswire

Mar. 31, 2026

Aptose Biosciences Announces Results of Special Shareholders Meeting; Announces Receipt of Final Court Approval of Plan of Arrangement; Reports Year End 2025 Results and Corporate Highlights

GlobeNewswire

Mar. 31, 2026

HCW Biologics Reports Fourth Quarter 2025 and Fiscal Year 2025 Business Highlights and Financial Results

GlobeNewswire

Mar. 31, 2026

ZyVersa Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire

Mar. 31, 2026

20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress

GlobeNewswire

Mar. 31, 2026

NeuroSalt Claims Evaluated: What the Pink Salt Trick Research Says About Neuro Salt Supplementation for Nerve Health

GlobeNewswire

Mar. 31, 2026

Axe Compute Inc. Reports Full-Year 2025 Financial Results

GlobeNewswire

Mar. 31, 2026

Cognition Therapeutics CEO Issues Letter to Shareholders

GlobeNewswire

Mar. 31, 2026

Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 31, 2026

Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit

GlobeNewswire

Mar. 31, 2026

FibroBiologics Announces Successful Manufacturing of CYWC628 Drug Product to Support Upcoming Diabetic Foot Ulcer Clinical Trial

GlobeNewswire